-
1
-
2
-
3
-
4
-
5
-
6
On the Breeds of Cattle—Historic and Current Classifications
Veröffentlicht in Diversity
VolltextArtikel -
7
-
8
Marker‐assisted conservation of European cattle breeds: an evaluation
Veröffentlicht in Animal genetics
VolltextArtikel -
9
Differentiation of European cattle by AFLP fingerprinting
Veröffentlicht in Animal genetics
VolltextArtikel -
10
-
11
-
12
-
13
-
14
-
15
High dose epirubicin (120 mg/M2) plus vindesine is not an effective salvage regimen for advanced non small cell lung cancer priorly treated by a cisplatinum containing regimen : J.P. Sculier, G. Bureau, J. Thiriaux, P. Mommen, M. Paesmans, J. Klastersky for the European Lung Cancer Working Party. Institut Jules Bordet, Brussels, Belgium
Veröffentlicht in Lung cancer (Amsterdam, Netherlands)
VolltextArtikel -
16
Analysis of survival data in 1052 patients with an advanced unresectable non small cell lung cancer: Application of a recursive partitioning and amalgamation algorithm (RECPAM) : M. Paesmans, J.P. Sculier, P. Libert, G. Bureau, O. Van Cutsem, J. Thiriaux, P. Mommen and J. Klastersky for the European Lung Cancer Working Party. Institut Jules Bordet, Bruxelles, Belgium
Veröffentlicht in Lung cancer (Amsterdam, Netherlands)
VolltextArtikel -
17
Prognostic factors for response to platinum-based chemotherapy programs in patients with unresectable non small cell lung cancer (NSCLC) : M. Borges, J.P. Sculier, M. Paesmans, P. Libert, G. Bureau, O. Van Cutsem, J. Thiriaux, P. Mommen and J. Klastersky for the European Lung Cancer Working Party. Institut Jules Bordet, Bruxelles, Belgium
Veröffentlicht in Lung cancer (Amsterdam, Netherlands)
VolltextArtikel -
18
Long term survival after chemotherapy in patients with advanced unresectable non small cell lung cancer (NSCLC): A report by the European lung cancer working party : J.P. Sculier, M. Paesmans, P. Libert, G. Bureau, J. Thiriaux, O. Van Cutsem, P. Mommen, J. Klastersky, Institut Jules Bordet, Bruxelles, Belgium
Veröffentlicht in Lung cancer (Amsterdam, Netherlands)
VolltextArtikel -
19
Weekly administration of moderate doses of cisplatin (25 mg/m2) and carboplatin (100 mg/m2) as salvage chemotherapy for small cell lung cancer : J.P. Sculier, J. Thiriaux, G. Bureau, J.J. Lafitte, P. Recloux, M. Paesmans, P. Mommen and J. Klastersky for the European Lung Cancer Working Party; Institut Jules Bordet, Brussels, Belgium
Veröffentlicht in Lung cancer (Amsterdam, Netherlands)
VolltextArtikel -
20
A phase III randomized study comparing 6 courses of chemotherapy alone versus 3 courses of chemotherapy followed by locoregional irradiation in patients with non metastatic unresectable non small cell lung cancer (NSCLC): Report on activity of induction chemotherapy : V. Giner, J.P. Sculier, P. Opalka, O. Van Cutsem, P. Recloux, G. Bureau, J. Thiriaux, J. Baumöhl, J. Schmerber, P. Mommen, M. Paesmans, P. Van Houtte and J. Klastersky for the European Lung Cancer Working Party. Institut Jules Bord
Veröffentlicht in Lung cancer (Amsterdam, Netherlands)
VolltextArtikel